GlassScriptPhysician profile
Steven C Golinowski
NPI 1528092020
$3,085.18
in general payments reported to CMS, 2019-2025
18 companies · $550 in 2025
The $550 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $685 · 2020: $94.60 · 2021: $861 · 2022: $526 · 2023: $192 · 2024: $177 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,127.57 | 2020-2025 | Dovato, Cabenuva |
| Gilead Sciences, INC. | $478.14 | 2019-2021 | |
| Janssen Products, LP | $366.39 | 2019-2022 | |
| Medtronic, INC. | $162.56 | 2025 | Osteocool Rf Ablation System |
| Merck Sharp & Dohme LLC | $154.02 | 2019-2021 | |
| Renalytix Ai, INC. | $141.06 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Esperion Therapeutics, INC. | $124.59 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $124.58 | 2022 | |
| Neuronetics, INC. | $95.13 | 2022 | |
| Echosens North America, INC. | $94.33 | 2025 | Fibroscan |
| Janssen Biotech, INC. | $50.98 | 2021-2022 | |
| Novo Nordisk INC | $40.68 | 2021 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Ardelyx, INC. | $22.99 | 2024 | Ibsrela |
| Dexcom, INC. | $22.36 | 2023 | Dexcom G6 Transmitter |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.61 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.97 | 2019 | |
| Organon LLC | $14.74 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Golinowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.